Cargando…
Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors
BACKGROUND: We investigated the clinical outcome in patients whose cavitary bone defects were treated with beta-tricalcium phosphate (β-TCP) after surgical removal of benign tumors. METHODS: Between March 2015 and December 2015, 20 patients who underwent operation for bone tumors were enrolled into...
Autores principales: | Chung, Haksun, Kim, Sanghyo, Chung, So Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Orthopaedic Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526132/ https://www.ncbi.nlm.nih.gov/pubmed/31156777 http://dx.doi.org/10.4055/cios.2019.11.2.233 |
Ejemplares similares
-
Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours
por: Razii, Nima, et al.
Publicado: (2023) -
Bone regeneration of calvarial defect using marine calcareous-derived beta-tricalcium phosphate macrospheres
por: Chou, Joshua, et al.
Publicado: (2014) -
Efficacy and Safety of Beta-Tricalcium Phosphate/Polylactic-Co-Glycolic Acid for Implantation of Bone Defects
por: Tokeshi, Soichiro, et al.
Publicado: (2023) -
Efficacy of soluble lansoprazole-impregnated beta-tricalcium phosphate for bone regeneration
por: Mishima, Kenichi, et al.
Publicado: (2022) -
Correlation between anterior thigh pain and morphometric mismatch of femoral stem
por: Chung, Haksun, et al.
Publicado: (2019)